Healthcare -
Biotechnology - NASDAQ - US
$ 2.85
-5.94 %
$ 182 M
Market Cap
-2.48
P/E
LRMR - CAPITAL EXPENDITURES
Capital Expenditures LRMR - Larimar Therapeutics, Inc.
-164 K
LAST VALUE
29.82%
2 YEAR CAGR
-8.71%
5 YEAR CAGR
-25.44%
10 YEAR CAGR